The Latest Breaking News from Wainwright Co

16 Analysts Assess Coinbase Glb: What You Need To Know

Ratings for Coinbase Glb (NASDAQ:COIN) were provided by 16 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Benzinga · Dec 9, 2024

Critical Insights From Pharming Analyst Ratings: What You Need To Know

6 analysts have expressed a variety of opinions on Pharming (NASDAQ:PHAR) over the past quarter, offering a diverse set of opinions from bullish to bearish.

Benzinga · Dec 9, 2024

Demystifying CG Oncology: Insights From 7 Analyst Reviews

7 analysts have expressed a variety of opinions on CG Oncology (NASDAQ:CGON) over the past quarter, offering a diverse set of opinions from bullish to bearish.

Benzinga · Dec 6, 2024

Navigating 5 Analyst Ratings For NovoCure

5 analysts have shared their evaluations of NovoCure (NASDAQ:NVCR) during the recent three months, expressing a mix of bullish and bearish perspectives.

Benzinga · Dec 2, 2024

The Latest Analyst Ratings For Femasys

During the last three months, 5 analysts shared their evaluations of Femasys (NASDAQ:FEMY), revealing diverse outlooks from bullish to bearish.

Benzinga · Nov 27, 2024

TG Therapeutics Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

TG Therapeutics (NASDAQ:TGTX) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Benzinga · Nov 25, 2024

What Analysts Are Saying About Rockwell Medical Stock

Ratings for Rockwell Medical (NASDAQ:RMTI) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Benzinga · Nov 25, 2024

A Glimpse Into The Expert Outlook On Rhythm Pharmaceuticals Through 13 Analysts

Rhythm Pharmaceuticals (NASDAQ:RYTM) has been analyzed by 13 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Benzinga · Nov 25, 2024